Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis

@inproceedings{Liu2013AnnexinAI,
  title={Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis},
  author={Zhikun Liu and Q H Ling and Jianguo Wang and Hai-Yang Xie and Xiao Xu and Shusen Zheng},
  booktitle={Oncology letters},
  year={2013}
}
In China, hepatocellular carcinoma (HCC) usually develops following a long history of chronic hepatitis B infection or cirrhosis. To evaluate the diagnostic role of annexin A2 (ANXA2), a possible tumor marker, in patients with hepatitis B virus (HBV)-related HCC, particularly those with a history of cirrhosis, the present study prospectively enrolled 87 patients with HBV-related HCC (with cirrhosis), 39 patients with HBV-related cirrhosis and 27 healthy controls. The expression levels of serum… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 24 references

Similar Papers

Loading similar papers…